Author
Listed:
- William Whyte
(Massachusetts Institute of Technology)
- Debkalpa Goswami
(Massachusetts Institute of Technology)
- Sophie X. Wang
(Massachusetts Institute of Technology
Beth Israel Deaconess Medical Center)
- Yiling Fan
(Massachusetts Institute of Technology)
- Niamh A. Ward
(Massachusetts Institute of Technology
National University of Ireland Galway)
- Ruth E. Levey
(National University of Ireland Galway)
- Rachel Beatty
(National University of Ireland Galway)
- Scott T. Robinson
(National University of Ireland Galway
Trinity College Dublin)
- Declan Sheppard
(University Hospital)
- Raymond O’Connor
(National University of Ireland Galway)
- David S. Monahan
(Massachusetts Institute of Technology
National University of Ireland Galway)
- Lesley Trask
(National University of Ireland Galway)
- Keegan L. Mendez
(Harvard-MIT Program in Health Sciences and Technology)
- Claudia E. Varela
(Harvard-MIT Program in Health Sciences and Technology)
- Markus A. Horvath
(Harvard-MIT Program in Health Sciences and Technology)
- Robert Wylie
(National University of Ireland Galway)
- Joanne O’Dwyer
(Massachusetts Institute of Technology
National University of Ireland Galway)
- Daniel A. Domingo-Lopez
(National University of Ireland Galway)
- Arielle S. Rothman
(Massachusetts Institute of Technology)
- Garry P. Duffy
(National University of Ireland Galway
Trinity College Dublin)
- Eimear B. Dolan
(National University of Ireland Galway)
- Ellen T. Roche
(Massachusetts Institute of Technology
Massachusetts Institute of Technology
Harvard-MIT Program in Health Sciences and Technology)
Abstract
Fibrous capsule (FC) formation, secondary to the foreign body response (FBR), impedes molecular transport and is detrimental to the long-term efficacy of implantable drug delivery devices, especially when tunable, temporal control is necessary. We report the development of an implantable mechanotherapeutic drug delivery platform to mitigate and overcome this host immune response using two distinct, yet synergistic soft robotic strategies. Firstly, daily intermittent actuation (cycling at 1 Hz for 5 minutes every 12 hours) preserves long-term, rapid delivery of a model drug (insulin) over 8 weeks of implantation, by mediating local immunomodulation of the cellular FBR and inducing multiphasic temporal FC changes. Secondly, actuation-mediated rapid release of therapy can enhance mass transport and therapeutic effect with tunable, temporal control. In a step towards clinical translation, we utilise a minimally invasive percutaneous approach to implant a scaled-up device in a human cadaveric model. Our soft actuatable platform has potential clinical utility for a variety of indications where transport is affected by fibrosis, such as the management of type 1 diabetes.
Suggested Citation
William Whyte & Debkalpa Goswami & Sophie X. Wang & Yiling Fan & Niamh A. Ward & Ruth E. Levey & Rachel Beatty & Scott T. Robinson & Declan Sheppard & Raymond O’Connor & David S. Monahan & Lesley Tras, 2022.
"Dynamic actuation enhances transport and extends therapeutic lifespan in an implantable drug delivery platform,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32147-w
DOI: 10.1038/s41467-022-32147-w
Download full text from publisher
References listed on IDEAS
- Kuen Yong Lee & Martin C. Peters & Kenneth W. Anderson & David J. Mooney, 2000.
"Controlled growth factor release from synthetic extracellular matrices,"
Nature, Nature, vol. 408(6815), pages 998-1000, December.
- Donghui Zhang & Qi Chen & Yufang Bi & Haodong Zhang & Minzhang Chen & Jianglin Wan & Chao Shi & Wenjing Zhang & Junyu Zhang & Zhongqian Qiao & Jin Li & Shengfu Chen & Runhui Liu, 2021.
"Bio-inspired poly-DL-serine materials resist the foreign-body response,"
Nature Communications, Nature, vol. 12(1), pages 1-12, December.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Xianchi Zhou & Zhouyu Lu & Wenzhong Cao & Zihao Zhu & Yifeng Chen & Yanwen Ni & Zuolong Liu & Fan Jia & Yang Ye & Haijie Han & Ke Yao & Weifeng Liu & Youxiang Wang & Jian Ji & Peng Zhang, 2024.
"Immunocompatible elastomer with increased resistance to the foreign body response,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Donghui Zhang & Jingjing Liu & Qi Chen & Weinan Jiang & Yibing Wang & Jiayang Xie & Kaiqian Ma & Chao Shi & Haodong Zhang & Minzhang Chen & Jianglin Wan & Pengcheng Ma & Jingcheng Zou & Wenjing Zhang , 2021.
"A sandcastle worm-inspired strategy to functionalize wet hydrogels,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32147-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.